Gerecht and Mao named new INBT leadership

Leadership duties for Johns Hopkins Institute for NanoBioTechnology (INBT) will pass to professors Sharon Gerecht and Hai-Quan Mao of the Whiting School of Engineering, effective January 1, 2017. Gerecht will serve as Director and Mao will serve as Associate Director. Current INBT director, Peter Searson of the Department of Materials Science and Engineering, and Associate Director, Denis Wirtz, the University’s Vice Provost for Research and Theophilus H. Smoot Professor in the Department of Chemical and Biomolecular Engineering, will step down after 10 years; they will remain at Hopkins.

gercht-mao

Sharon Gerecht, Hai-Quan Mao will lead INBT effective Jan. 1, 2017.

“Both Sharon and Hai-Quan embrace INBT’s original vision, which seeks to bring together researchers from diverse disciplines to solve problems at the interface of nanotechnology and medicine,” said INBT’s founding director Peter Searson and Joseph R. and Lynn P. Reynolds Professor. “Their contributions to multidisciplinary research, commitment to technology transfer, and vision in educating the next generation of leaders in nanobiotechnology made Sharon and Hai-Quan ideal candidates for the job. Denis and I are delighted to pass the baton to two outstanding faculty members who both have a remarkable track record of innovation and translation.”

Gerecht, the Kent Gordon Croft Investment Faculty Scholar, is a professor in the Department of Chemical and Biomolecular Engineering. Her research focuses on ways to control the fate of stem cells, which are the most fundamental building blocks of tissues and organs. She was the inaugural winner of the University President’s Frontier Award.

Mao is a professor in the departments of Materials Science and Engineering and Biomedical Engineering, and currently holds a joint appointment in the Translational Tissue Engineering Center at Johns Hopkins School of Medicine. His research is focused on engineering novel nano-structured materials for nerve regeneration and therapeutic delivery. He won the University’s 2015 Cohen Translational Engineering Award and a 2015 University Discovery Award.

“Since its inception, INBT has been a leader in cross-divisional research at Johns Hopkins. Under Sharon and Hai-Quan’s leadership will further the institute’s mission to advance research and education at the intersection of engineering, medicine, and health.” said Whiting School dean Ed Schlesinger.

INBT was launched in May 2006, with $4M funding from Senator Barbara Mikulski.

“At that time, Denis and I anticipated that there would be new opportunities for physical scientists and engineers to collaborate with biomedical researchers and clinicians in solving problems in medicine, specifically problems at the molecular and nanoscale,” Searson said. “Since multidisciplinary collaborations across departments and divisions were not prevalent then, the deans of medicine, public health, engineering, and arts and sciences supported the creation of the institute to build the infrastructure to support and promote these efforts.” Then university president, William H. Brody arranged a meeting with Senator Barbara Mikulski, who officially launched the Institute on May 15, 2016.

Today INBT has more than 250 affiliated faculty members. INBT’s research occurs across all university campuses, but primarily in the 26,000 square feet of laboratory space for the 18 researchers located in Croft Hall on the University’s Homewood campus. Croft Hall serves as a focal point for INBT activities and headquarters for staff, where researchers from eight departments in the Whiting School of Engineering and the Johns Hopkins School of Medicine collaborate under one roof.

“INBT has catalyzed multidisciplinary research across the university,” said Landon King, executive vice dean of the Johns Hopkins School of Medicine. “The collaborations between engineers, scientists, and clinicians initiated by INBT have led to numerous discoveries, partnerships, and new companies.”

Since its launch, INBT researchers have generated more than $80 million in research funding. The institute manages a diverse portfolio of research projects and has established numerous research centers and initiatives, including the Physical Sciences-Oncology Center, Center for Cancer Nanotechnology Excellence, Center for Digital Pathology, and the Blood-Brain Barrier working group. INBT researchers have created more than 15 companies including Circulomics, Cancer Targeting Systems, Gemstone Biotherapeutics, Asclepyx, and LifeSprout.

INBT supports numerous education and training programs. An award from the Howard Hughes Medical Institute in 2006 provided the support for the development of the NanoBio training program. With funding from the National Institutes of Health and the National Science Foundation, 89 PhDs have been awarded to students from eight departments in the Whiting School of Engineering and the Krieger School of Arts and Sciences. INBT also supports a post-doctoral training program.

INBT is home to an NSF Research Experience for Undergraduates (REU) program, which has supported 104 students over eight years, and receives more than 700 applicants for 10 internships each year. All of these students have gone on to graduate studies in science and engineering. In addition, INBT hosts an International Research Experience for Students (IRES) program, providing internships for undergraduate and graduate students to work at IMEC, a world-class nano-fabrication facility in Leuven, Belgium.

In 2015, INBT launched an undergraduate research group as a way to build a community of students working in research labs. The more than 100 undergraduate student researchers are represented by the undergraduate leadership council, which organizes numerous professional development and social events to support and promote the research experience.

Story by Mary Spiro

Oxygen’s role in cancer spread

Cancer cells need oxygen to survive, as do most other life forms, but scientists had never tracked their search for oxygen in their early growth stages until now — a step toward a deeper understanding of one way cancer spreads that could help treat the disease.

In a paper published online by the Proceedings of the National Academy of Sciences, bioengineers from Johns Hopkins University and the University of Pennsylvania report results of their work showing how sarcoma cells in mice pursue a path toward greater concentrations of oxygen, almost as if they were following a widening trail of breadcrumbs. That path is suggested to lead the cells to blood vessels, through which the cells can spread to other parts of the body.

Oxygen-front.svg“If you think about therapeutic targets, you could target this process specifically,” said Sharon Gerecht, professor in Johns Hopkins University’s Whiting School of Engineering’s Department of Chemical and Biomolecular Engineering and a lead author of the study. She acknowledged that clinical application is a long way off, but said these results reached after three years of study in her laboratory provide clues about a key part of the life cycle of soft-tissue sarcomas and also a proven way to test cancer treatments in the lab. (Gerecht is an associate director of Johns Hopkins Institute for NanoBioTechnology.)

Sarcoma is a cancer that affects connective tissue, including bones, muscles, tendons, cartilage, nerves, fat and some blood vessels.  The study focused specifically on soft tissue sarcoma that does not affect bones, a type diagnosed in some 13,000 patients a year in the United States. Roughly a quarter to half of those patients develop recurring and spreading, or metastasizing, cancer.

Cancers of all sorts are known to thrive with little oxygen, and researchers have looked at the role of low oxygen conditions in tumor development. Less well understood is how cancer cells respond to varying oxygen concentrations in their early stages. That was the focus of this research.

Gerecht and her seven co-authors – four affiliated with Johns Hopkins, three with Penn – tracked thousands of early stage cancer cells taken from mice as they moved through a mockup of bodily tissue made of clear gel in a petri dish.  The hydrogel – a water-based material with the consistency of gelatin – replicates the environment surrounding cancer cells in human tissue.

Kyung Min Park, then a postdoctoral researcher in the Johns Hopkins lab, developed the hydrogel-cancer cell system, and Daniel Lewis, a Johns Hopkins graduate student, analyzed cellular migration and responses to rising oxygen concentrations, or “gradients.”

For this experiment, the hydrogels contained increasing concentrations of oxygen from the bottom of the hydrogel to the upper layer.  That allowed researchers to track how cancer cells respond to different levels of oxygen, both within a tumor and within body tissues.

Analysis of sarcoma tumors in mice, for instance, shows that the largest tumors have a large area of very low oxygen at the center. Smaller tumors have varying oxygen concentrations throughout.

The researchers’ first step was to show that cancer cells migrate more in low-oxygen or “hypoxic” hydrogels as compared with hydrogels containing as much oxygen as the surrounding atmosphere. They then looked at the direction of the cell movement.

In the hydrogel, which mimics the oxygen concentrations in smaller tumors, cells were found to move from areas of lower oxygen to higher. Researchers also found that the medication minoxidil – widely used to treat hair loss and known by its trade name Rogaine – stopped the movement of cancer cells through the hydrogel.

Cancer cells are known to modify their environment to make it easier for them to move through it, but this study takes that understanding a step further, Gerecht said.

“We did not know it was the oxygen” that effectively directs the movement, she said. “It’s suggesting oxygen gradient affects early stages of the metastasis process.”

The study also demonstrates the three-dimensional hydrogel model as an effective tool for testing cancer treatments in a laboratory, the authors wrote. Gerecht said a human patient’s cancer cells could be placed into the hydrogel just as the mouse cells were, allowing clinicians to see how they respond before treatments are given to patients.

The research was supported by the National Cancer Institute (grants CA153952 and CA158301), the American Heart Association (61675), the National Science Foundation (1054415) and Johns Hopkins University’s President’s Frontier Award.

Story by Arthur Hirsch: ahirsch6@jhu.edu

INBT science, engineering film fest features student works

Johns Hopkins Institute for NanoBioTechnology hosts its annual Science and Engineering Film fest on Wednesday, July 20 at 11 a.m. to noon in the Arellano Theater in Levering Hall on the Homewood Campus. Films were created this summer by graduate students in INBT’s course on Communication for Scientists and Engineers and will showcase current research happening in institute affiliated laboratories. Three films will be shown and the students who made them will be available for questions after each one. The event is free and open to the public.

Slide1

Affiliates receive state stem cell research awards

Several researchers associated with Johns Hopkins Institute for NanoBioTechnology have received grants from the Maryland Stem Cell fund.

In the Whiting School of Engineering, awardees include Sharon Gerecht, Kent Gordon Croft Investment Management Faculty Scholar in the Whiting School of Engineering’s Department of Chemical and Biomolecular Engineering and associate director of the Institute for NanoBioTechnology, and Warren Grayson, associate professor in the Department of Biomedical Engineering. Both received MSCRF Investigator Initiated Grants. Gerecht’s stem cell project targets diabetic wound treatment, and Grayson’s targets volumetric muscle loss.

2000px-Stem_cell_treatments.svgIn addition, Dhruv Vig, a post-doctoral student in INBT and the Department of Mechanical Engineering, received one of the organization’s Post-Doctoral Fellowship Grants for his project “Geometric Cues in the Establishment and Maintenance of Heterogeneous Stem Cell Colonies.”

According to Vig, the goal of this investigation is to introduce a new way of characterizing the potency and/or differentiation of human pluripotent stem cells.

“Our work uses an innovative blend of mathematical modeling and experimental approaches to shed light on the role of physical forces and geometric constraint involved in the establishment and maintenance of proper stem cell functions,” explains Vig, who is advised by Gerecht and Sean Sun, professor and vice-chair in the Department of Mechanical Engineering.

Other INBT affiliated faculty members who received the grants include Guo-li Ming, M.D., Ph.D., targeting schizophrenia and autism and Michael McMahon, Ph.D., targeting intervertebral disc degeneration, both from the Johns Hopkins School of Medicine.

Of the 26 MSCRP grants, 21 went to Hopkins-affiliated researchers. The purpose of these grants and fellowships is to promote state-funded stem cell research.

 

 

 

INBT summer seminars begin June 7 with Rong Li

As a service to the university community, Johns Hopkins Institute for NanoBioTechnology offers seminars with guest speakers on topics relevant to nanotechnology, medicine and engineering. All seminars will take place on select Tuesdays in Croft G40 at 2 p.m. Space is limited, so please RSVP to Camille Bryant at cbryant@jhu.edu. Schedule and locations are subject to change. Get a printable flyer here.

The Johns Hopkins UniversityThis summer, the speakers include the following:

  • June 7
    Polycystins: sensors and orchestrators at the crossroad of epithelial growth and differentiation
    Dr. Rong Li
  • June 21
    Technology transfer and licensing for researchers
    Ms. Emily Williams
    JHU, HealthIT
  • July 12
    Dissecting the role of matrix mechanics in the Tumor Ecosystem
    Dr. Kandice Tanner
    NIH
  • July 28
    Photonics solutions to complex problems in cancer research, nanoparticle drug delivery, and medical diagnosis
    Dr. Ishan Barman
  • August 23
    Multi-modal diagnostics and treatment of cancer using paramagnetic nanoparticles
    Dr. Israel Gannot
    JHU, Tel Aviv University

 

Cancer cells use two pathways to sense and move in tight quarters

COVER IMAGE CAPTION: Hung et al. describe two cooperating signaling modules by which cells sense and traverse confined spaces. Signaling output is optimized through complex feedback loops ultimately leading to efficient cell motility. Artist Jun Cen ( cenjun.com ) depicts a small diver exploring confined migration, which is symbolized by the large size and tangled arms of the octopus trying to squeeze into the cave.

Hung et al. describe cooperating signaling modules used by cells to sense and traverse confined spaces. Artist Jun Cen ( cenjun.com ) show a  small diver exploring confined migration symbolized by the tangled arms of the octopus trying to squeeze into the cave.

Like a bicycle messenger weaving through busy city streets, cancer cells are skilled at maneuvering through microenvironments. Researchers know they use complex signalling pathways to move through and sense their surroundings, but exactly how these pathways worked was unclear.  Now, researchers from the Konstantinos Konstantopoulos laboratory at Johns Hopkins University have determined that both calcium and the cell protein myosin play a role in a cooperative feedback loop that makes cancer cells champions of  motility even in a tight squeeze  Their work appears in the May 17, 2016 journal Cell Reports, and an artist’s interpretation of the study graces the journal’s cover.

Wei-Chien Hung was the lead author on a study that used microfabricated growth chambers featuring narrow channels that the cells had to move through.  As the cancer cells migrated through the device, they had to squeeze and stretch to fit into confined spaces. As the cell membrane stretched, it caused special stretch-activated channels (called Piezo1 channels) to open. When the channels opened, calcium ions could flow through the cell membrane into the cell. The additional calcium ions set off a cascade of biochemical events leading to the activation of myosin.

As a molecular motor, myosin drove the cancer cells to move forward.  Myosin also served as a sensor that directly responded to external force and stretched the membrane.  This opened the channels, allowing more calcium ions to flow in; myosin in turn was further activated and so on.  This feedback system maximized the signaling output of the two sensors.

Screen Shot 2016-05-24 at 3.57.00 PMKonstantopoulos, professor and chair of Department of Chemical and Biomolecular Engineering and an affiliated faculty member of Johns Hopkins Institute for NanoBioTechnology, says that the two ways of sensing the environment and signaling movement in a microenvironment makes the motility of cancer cells extremely efficient and highly effective in confined spaces, such as what might be found inside of a tumor cell mass. These two pathways also present two potential targets on which cancer researchers can focus further investigation in order to prevent cancer cell migration.

Other authors on the paper include Jessica Yang, Christopher Yankaskas, Joy T. Yang and Jin Zhang. The research was funded in part by the NIH and the American Heart Association.

Written by Mary Spiro. For media inquiries regarding INBT, contact Mary Spiro at mspiro@jhul.edu

 

The subtle allure of materials science and engineering

You know what’s funny?

If you were to have asked me during my senior year of high school what Materials Science and Engineering (MSE) was, I wouldn’t have the slightest clue how to answer. Now, less than five years later, I’m sitting here writing this as a first-year MSE PhD student, and were I to be asked that question now, I could go on for hours about how it is one of the coolest, most interdisciplinary fields anyone could get themselves into.

MSE is often an overlooked discipline due to it not being a “major” (read: Mechanical, Chemical, Electrical) engineering discipline. What most people don’t realize, however, is that practically everything you do and take advantage of on a day-to-day basis, you have a materials engineer to thank for. That iPhone of yours you stare at for over an hour a day? It’s a materials masterpiece.

Consider how many times you’ve accidentally dropped your phone (whether it be on the ground or on your face while you’re laying in bed) without the screen cracking. You have the engineers at Corning to thank for that. Corning’s Gorilla Glass is no ordinary day-to-day window glass; it’s a special aluminosilicate glass that has undergone a process called ion exchange. Basically, what happens is you dip a sodium-containing glass into a hot bath of potassium ions, where a literal exchange happens between the sodium and the potassium atoms. Since potassium is ever so slightly larger than sodium, the glass is put under compression. If anyone wants to break this glass, they must first overcome the genius behind its reinforcement. You can read more about how gorilla glass is made [here].

gorillaglass

A sample of corning’s Gorilla Glass put under a three-point bending test.

The materials genius behind the iPhone isn’t limited to just its screen. The production of the hardware that makes your phone so fast was also a materials problem—getting those two billion transistors to fit on a chip inside your iPhone took literal decades of work.

Problems like these are what brought me to take on MSE as my undergraduate major, but the interdisciplinary nature of the field is what convinced me to stay.

My “Intro to MSE” professor (and my eventual undergraduate research advisor), Dr. Laura Fabris, would often tell us about her research. She worked on the production of gold nanoparticles (?!) that could be used for disease/biological marker detection. Her research fascinated me, and was what originally got me interested in the region where materials and biology overlap. The more that I read about what was being done, the more I longed to be a part of it. These desires have brought me to the Johns Hopkins University for my graduate studies, and ultimately the Institute for NanoBioTechnology so that I could gain further insight and training on what is being done at the forefront of my field.

goldnanorods

Transmission Electron Micrograph of Gold Nanorods in solution.

Now that I’m here at Hopkins, I’ve found myself working on the synthesis and self-assembly of polymeric nanoparticles used for biomedical applications. Did you know that most drugs on the market that are used for treatment of diseases such as cancer are hydrophobic? Now, consider the fact that your body is about 60% water… This makes delivering drugs to certain areas of your body a huge problem, and has posed a challenge for hundreds of scientists and engineers. Using the polymeric nanoparticles my lab synthesizes, we can store these drugs in a safe “vehicle” so that they may safely arrive wherever they are needed. Cool, huh?

With that, I’d like to leave you with the video from Corning that truly was the tipping point to my choosing MSE. Although it no longer lines up with the direction I’m taking myself, it shows how the future lies in the hands of engineers who believe in the power of materials, and I hope I have inspired you to consider the impact materials make in both our everyday lives and the (not-so-distant) future.

Lazaro Pacheco is a first year PhD student in the Materials Science and Engineering department at the Johns Hopkins University. He is a member of the Herrera Lab, and he is currently working on measuring the polydispersity of polymer chains that are ‘grafted from’ a central polymeric backbone.

Media inquires about INBT should be directed to Mary Spiro at mspiro@jhu.edu.

Happy 10th Anniversary INBT

Happy 10th Anniversary INBT! Johns Hopkins Institute for NanoBioTechnology was established on May 16, 2006 with funding from the National Institutes of Health and NASA. Over the last decade, we have achieved many exceptional accomplishments and attained significant research milestones. INBT has attracted nearly $70 million in research funding and added more than 250 affiliated faculty members from across many divisions and departments of the university. INBT has launched several spin-off research centers, such as the Physical Sciences Oncology Center and the Center for Cancer Nanotechnology Excellence. The Institute has also initiated nanobio-related training programs for students from pre-college through the postdoctoral level, such as the NanoBio Research Experience for Undergraduates and the International Research Experience for Students, in which participants travel to Belgium to conduct nanobio research in IMEC’s world-class research facility. Hundreds of students have completed these programs and our alumni hold outstanding positions within industry and academia. INBT also has developed strong corporate partnerships and continues to seek ways to move innovative research that solves the pressing problems in human health from the laboratory to the marketplace.

Dongjin Shin (right) of the Wang lab (French/ INBT)

Dongjin Shin (right) of the Jeff Wang lab (French/ INBT)

On April 21, INBT hosted an open house and anniversary celebration that attracted more than 100 people to its headquarters in Croft Hall on the Homewood campus of the Johns Hopkins University. We also invited visitors to participate in 15 hands-on demonstrations developed by labs located in the building.

Thanks to everyone who helped celebrate with us on that day and to those who continue to support us every day as INBT furthers its mission as a hub for innovative multidisciplinary research.  Click below to view a sideshow of photos from our open house. Photos by INBT staff members Jon French and Mary Spiro.

This slideshow requires JavaScript.

 

Active Matter Physics: combining physics with living things

The world of physics covers a wide range of length scale: from nanometer scale atoms all the way up to stars and galaxies. When speaking of physics, people tend to think of things that are not “alive”, such as material physics, particle physics, astronomy, etc.

Figure1

Figure.1 Caption: Bird flock in vedanthangal (author: Vinoth Chandar) (https://commons.wikimedia.org/wiki/File:Bird_flock_in_vedanthangal.jpg)

In the last decade, a new area of physics called active matter physics has arisen. To better understand active matter physics, it is helpful to introduce a similar field, soft matter physics. Soft matter physics mainly studies the group behavior of particles with the size of several micrometers. Behavior of a system at such a small size is largely determined by thermal dynamics. Glass, soft gels, granular material are all studied by soft matter physics.

Active matter physics, on the other hand, is very similar to soft matter physics, since it also mainly focuses on studying the group behavior of a system that arises from the interactions of “particles”. However, one of the crucial differences between active matter physics and soft matter physics is that active matter physics studies particles that are “active”, which means that by consuming energies from the environment, they can produce self-motility. Systems studied by active matter physics can range from bird flocks (Fig.1) to cytoskeleton structures inside cells (Fig.2).

MEF_microfilaments

Figure.2 caption: actin cytoskeleton of mouse embryo fibroblasts (author: Y tambe) (https://commons.wikimedia.org/wiki/File:MEF_microfilaments.jpg)

Studying active matter physics provides another perspective for understanding the emerging behavior in a biological system. For instance, there has been work done on simulating cell motion in densely packed tissues. Physicists using tools from statistical mechanics have successfully simulated how cells move around inside tissues and have found that there is a transition where cell motility changes from liquid-like flowing into solid-like jiggling around its initial position. They are able to plot out the phase diagram of such transitions in a space determined by three parameters: cell moving speed, persistence time along a single cell track, and a shape index that characterizes the competition between cell-cell adhesion and cortical tension. Such results provide an insight into the understanding of similar solid-to-liquid transition observed in cancer progressions.

About the author: Yu Shi is a 4th year PhD student in the Department of Physics & Astronomy at Johns Hopkins University. He is in Prof. Daniel Reich’s lab, and his current works focus on studying dynamic properties of actin-myosin system inside cells using micro-patterned substrate.

Reference article:

1.     Dapeng Bi, X. Yang, M. C. Marchetti, M. L. Manning, “Motility-driven glass transitions in biological tissues,” Phys. Rev X, arXiv:1509.06578 (2015).

2.     M.C. Marchetti, J.F. Joanny, S. Ramaswamy ,  T.B. Liverpool, J. Prost,  Madan Rao,  and R. Aditi Simha,” arXiv:1207.2929v1 (2012)

 

Media inquiries regarding INBT should be directed to Mary Spiro, at mspiro@jhu.edu.

Remsen Lecture focuses on nanoelectronics for brain science

Charles M. Lieber of Harvard University will present the 71st Remsen Lecture, Thursday, May 12 at 6 p.m. in 101 Remsen Hall. He will deliver the talk “Nanoelectronic Tools for Brain Science”  and will receive the Remsen Award from the Maryland section of the American Chemical Society. The event is free and open to the public. Light refreshments will be served at 5:30 in Room 140 and a reception will follow the lecture, also in Room 140.

Charles M. Lieber from Asianscientist.com

Charles M. Lieber from Asianscientist.com

Charles M. Lieber received his undergraduate degree in chemistry from Franklin and Marshall College and carried out his doctoral studies at Stanford University, followed by postdoctoral research at the California Institute of Technology. In 1987 he assumed an Assistant Professor position at Columbia University, embarking on a new research program addressing the synthesis and properties of low-dimensional materials. He moved to Harvard University in 1991 and now holds a joint appointment in the Department of Chemistry and Chemical Biology, as the Mark Hyman Professor of Chemistry, and the Harvard John A. Paulson School of Engineering and Applied Sciences.

He serves as the Chair of the Department of Chemistry and Chemical Biology. At Harvard, Lieber has pioneered the synthesis of a broad range of nanoscale materials, the characterization of the unique physical properties of these materials and the development of methods of hierarchical assembly of nanoscale wires, together with the demonstration of applications of these materials in nanoelectronics, nanophotonics, and nanocomputing, as well as pioneering the field of nano-bioelectronics where he has made seminal contributions to biological and chemical sensing, the development of novel nanoelectronic cell probes, and cyborg tissues.

Lieber’s work has been recognized by a number of awards, including the first ever Nano Research Award, Tsinghua University Press/Springer (2013); IEEE Nanotechnology Pioneer Award (2013); Willard Gibbs Medal (2013); Wolf Prize in Chemistry (2012); ACS Inorganic Nanoscience Award (2009); NBIC Research Excellence Award, University of Pennsylvania (2007); Nanotech Briefs Nano 50 Award (2005); ACS Award in the Chemistry of Materials (2004); World Technology Award in Materials (2004 and 2003); Scientific American 50 Award in Nanotechnology and Molecular Electronics (2003); APS McGroddy Prize for New Materials (2003); MRS Medal (2002); Feynman Prize in Nanotechnology (2001); NSF Creativity Award (1996); and ACS Award in Pure Chemistry (1992).

Lieber is an elected member of the National Academy of Sciences, the American Academy of Arts and Sciences and the National Academy of Inventors, and Fellow of the American Chemical Society, Materials Research Society, and American Physical Society. He is Co-Editor of Nano Letters and serves on the Editorial and Advisory Boards of a large number of science and technology journals. Lieber also serves on the Technical Advisory Committee of Samsung Electronics. He has published over 380 papers and is the principal inventor on 40 patents. In his spare time, Lieber has been active in commercializing nanotechnology, and founded the nanotechnology company Nanosys, Inc. in 2001 and the nanosensor company Vista Therapeutics in 2007, and nucleated Nantero, Inc. from his laboratory in 2001.